Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Active not recruiting 3Recruiting 2Withdrawn 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Papillomavirus Infections 1Atypical Squamous Cells of the Cervix 1

Interventions

Specimen Handling 313Magnetic Resonance Spectroscopy 272pembrolizumab 263Carboplatin 190Cyclophosphamide 177Biopsy 177Cisplatin 165Paclitaxel 137Gemcitabine 137Bevacizumab 122fludarabine 115Nivolumab 114Radiotherapy 111venetoclax 98Oxaliplatin 97Fluorouracil 87Docetaxel 85Dexamethasone 83Capecitabine 83Pemetrexed 76Drug Therapy 76Rituximab 75Leucovorin 71durvalumab 70Radiosurgery 67Doxorubicin 64Blood Specimen Collection 64Standard of Care 63Injections 62atezolizumab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colposcopy × 90 days × Clear all
NCT07281430 2026-05-13

LMI-001-A-S04

National Cancer Institute (NCI)

Phase NA Recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07480902 2026-03-18

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

Timser SAPI de CV

Phase NA Recruiting
558 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡